📰 Cerence Inc News
Page 2 - Cerence Inc News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Cerence Inc. Real-time updates on events, politics, business and more.
April 5, 2024
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC , announces that KSF continues its investigation into Cerence Inc. . On...
March 26, 2024
Cerence Inc (NASDAQ:CRNC), a company specializing in creating unique, moving experiences for the automotive world through voice, touch, gesture, emotion, and gaze innovations, has reported an insider sell according to a recent SEC filing.
February 21, 2024
A ‘two-way conversation’ will soon be possible with your new Volkswagen
February 7, 2024
Cerence Inc. (NASDAQ:CRNC) Q1 2024 Earnings Call Transcript February 6, 2024 Cerence Inc. misses on earnings expectations. Reported EPS is $0.4844 EPS, expectations were $0.9. Cerence Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and thank you for standing […]
February 6, 2024
Revenue and Profitability Soar as Company Secures Key AI Partnerships
February 6, 2024
WASHINGTON-Four years ago, when President Biden clinched the Democratic nomination, he aggressively courted progressives, forming an alliance that helped propel him to the White House and has... -February 06, 2024 at 06:15 am EST - MarketScreener
February 6, 2024
BURLINGTON, Mass. — BURLINGTON, Mass. — Cerence Inc. on Tuesday reported profit of $23.9 million in its fiscal first quarter. The Burlington, Massachusetts-based company said it had...
January 31, 2024
Volkswagen establishes an independent AI lab for cutting-edge digital prototypes, focusing on AI-optimized charging, predictive maintenance, and voice recognition, fostering global tech collaborations for innovation.
January 29, 2024
VANCOUVER, Washington, Jan. 29, 2024 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB:CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for
January 29, 2024
VANCOUVER, Washington, Jan. 29, 2024 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) (CytoDyn or the Company), a biotechnology company develo...